Search Results 191-200 of 23811 for prostate cancer
... prostate cancer. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...
Castration-resistant prostate cancer patients with rising prostatic specific antigen (PSA) are eligible for this study. 11C-Choline PET/CT will be used to ...
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer. Print details. Share; Facebook · Twitter. Overview; Participation eligibility ...
Head and neck cancers; Liver cancer; Lung cancer; Lymphoma; Pancreatic cancer; Pituitary gland tumors; Prostate cancer; Sarcoma; Tumors affecting the spine ...
Prostate gland · Photoselective vaporization of the prostate (PVP). A laser is used to melt away (vaporize) excess prostate tissue and enlarge the urinary ...
Prostate cancer cells make excessive amounts of this protein, so an elevated or increasing PSA level is a possible sign of prostate cancer. That said, the ...
... prostate cancer treatment compared to other minority groups. The study was recently published in Mayo Clinic Proceedings. Researchers say that it has long ...
... prostate cancer. This medicine is available only with your doctor's prescription. This product is available in the following dosage forms: Tablet. Back to ...
If the first therapy to treat prostate cancer doesn't work, there are other options available — with one exception. ... According to Lonnie Fynskov, a Mayo Clinic ...
A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.